Therefore, the nanoparticle-encapsulated curcumin treatment reduced P2Y12 receptor-mediated Akt activation in the DRG, thereby relieving mechanical and thermal hyperalgesia in DM rats. This evidence concerns the gene AKT1 and diabetes mellitus.